等待開盤 12-19 09:30:00 美东时间
+0.110
+1.51%
今日重点评级关注:HC Wainwright & Co.:维持BioCryst Pharma"买入"评级,目标价从30美元升至32美元;TD Cowen:上调Milestone Pharmaceuticals评级至"买入",目标价8美元
12-16 09:36
Compass Point analyst Jason Stewart initiates coverage on Orchid Island Cap (NYSE:ORC) with a Neutral rating and announces Price Target of $7.5.
12-16 00:46
Orchid Island Capital (ORC) declares $0.12/share monthly dividend, in line with previous. Forward yield 20.03% Payable Jan. 29; for shareholders of record Dec. 31; ex-div Dec. 31. See ORC Dividend Sco...
12-10 12:38
Direxion has rolled out five new single-stock ETFs offering amplified exposure to crypto platforms and AI infrastructure, with leveraged bets.
11-22 03:19
①过去一年间,美国劳动力市场一直呈现“不招聘、不裁员”的格局; ②但如今,“不招聘、多裁员”的趋势正日益明显,这可能正为美联储降息提供更多依据。
10-30 10:40
自唐纳德・特朗普上任以来,咖啡价格已飙升逾 25%,如今这一商品已成为美国民众食品购物篮中的 “痛点”,且终于引发了总统的关注。 上周末特朗普出访马来西...
10-28 18:45
Orchid Island Capital ( ($ORC) ) has shared an announcement. On October 27, 202...
10-27 21:29
当地时间10月22日,美国国会参议院未能通过共和党提出的临时拨款法案,联邦政府“停摆”僵局仍在持续。这是美国政府10月1日开始“停摆”以来,参议院第12次投...
10-27 20:45
Orchestra BioMed Holdings, Inc. announced the initiation of the Virtue Trial, a pivotal study comparing its Virtue® Sirolimus AngioInfusion™ Balloon (Virtue SAB) to the AGENT paclitaxel-coated balloon for treating coronary in-stent restenosis (ISR). Virtue SAB is a non-coated drug-eluting balloon designed to deliver a large dose of extended-release sirolimus, addressing limitations of traditional drug-coated balloons. The trial, which began enrol...
10-27 13:00
Orchid Island Cap (NYSE:ORC) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 10.34 percent. This is a 420 percent increase over losses of $(0.05) per share from the
10-24 04:52